| 2026-02-16 |
BWLEX6969479158 |
VKT PHARMA PRIVATE LIMITED |
6189.0 kg |
291229.0
|
XRF STC (TWENTY NINE)PACKAGES OFTADALAF IL TABLETS,USP MG NDC NO.:TADALAFIL TA BLETS,USP MG NDC NO.:INV NO :VKT/EX/ /-DT :--SB NO: DT:.. HS CODE: NET WT :. KGS |
| 2026-02-09 |
MAEU265316644 |
|
3949.95 kg |
291823.0
|
MEDROXYPR. MGML SASUS XML DSSG US FIL INVOICE OBD MEDROXYPR. MGML SASUS XML DSSG US FIL INVOICE OBD MEDROXYPR. MGML SASUS XML DSSG US FIL INVOICE OBD |
| 2026-02-09 |
MAEU265316642 |
|
4360.91 kg |
291823.0
|
MEDROXYPR. MGML SASUS XML DSSG US FIL INVOICE OBD MEDROXYPR. MGML SASUS XML DSSG US FIL INVOICE OBD MEDROXYPR. MGML SASUS XML DSSG US FIL INVOICE OBD MEDROXYPR. MGML SASUS XML DSSG US FIL INVOICE OBD |
| 2026-02-09 |
MAEU265316639 |
|
3837.91 kg |
291823.0
|
MEDROXYPR. MGML SASUS XML DSSG US FIL INVOICE OBD MEDROXYPR. MGML SASUS XML DSSG US FIL INVOICE OBD MEDROXYPR. MGML SASUS XML DSSG US FIL INVOICE OBD |
| 2026-02-02 |
BWLEX6959434376 |
VKT PHARMA PRIVATE LIMITED |
8740.0 kg |
902230.0
|
XRF STC (FOURTY PACKAGES) TADALAFIL TABL ETS, USP .MG(CT) X BLISTERS - NDC NO: -- XX= NOS TADALAFIL TABLETS,USP MG - DC NO:-- - X= NO S INV NO : VKT/EX//- D T :// SB NO: // HS COD E : NET WT :. KGS |
| 2026-02-02 |
BWLEX6959445719 |
VKT PHARMA PRIVATE LIMITED |
7442.0 kg |
902230.0
|
XRF STC (THIRTY SEVEN ) PACKAGES OFTADA LAFIL TABLETS, USP .MG(CT) X BLISTERS NDC NO:-- XX= NOS TA DALAFIL TABLETS,USP MG NDC NO:-- X= NO STADALAFIL TABLETS, USP MG - NDC NO:-- - X= N O S INV NO :VKT/EX//- DT :// SB NO: DT :// HS CODE : NEW WT :. KGS |
| 2026-01-30 |
BANQ1071503842 |
BESINS HEALTHCARE DISTRIBUTION FZ L |
9537.0 kg |
551312.0
|
TESTO G .% . . CTU USA TESTO G % MG G CTU USA TESTO G %MG .G CTU USA LOADED ON PALLETS NET WEIGHT: . KG DATALOGGERS: S- S- TESTO GEL % XG P CTU USA TESTO G % MG G CTU USA TESTO G %MG .G CTU USA LOADED ON PALLETS NET WEIGHT: . KG DATALOGGERS: S- S-<br/ |
| 2026-01-21 |
BWLEX6959390572 |
VKT PHARMA PRIVATE LIMITED |
7907.0 kg |
902230.0
|
X RF STC ( ) THIRTY SIXPACKAGES OF TADALAF IL TABLETS,USP MGNDC NO: - - X = NOS TADALAFIL TABLETS,USP MG ND C NO: - - X = NO S INV NO :VKT/EX/ / - DT : / / SB NO: DT: / / HS CODE : NETW T : . KGS TEMPERATURE TO BE SET AT + . C |
| 2025-12-20 |
BWLEX6959261210 |
VKT PHARMA PRIVATE LIMITED |
7377.0 kg |
902230.0
|
X RH STC (THIRTY FOUR)PACKAGES OFTADALAF IL TABLETS,USP . MG( CT) X BLISTERS - ND C NO: - - - X = NOSTADAL AFIL TABLETS,USP MG - NDC NO: - - - X = NO SINV NO:VKT/EX/ / - DT : / / SB NO: HS CODE : N ET WT : . KGS |
| 2025-11-22 |
BWLEX6959139689 |
VKT PHARMA PRIVATE LIMITED |
8907.0 kg |
902230.0
|
X RF STC PACKAGES OFTADALAFIL TABLETS,US P MG -NDC NO: - - - X = NOSINV NO :VKT/EX/ / - DT : / / S B NO: / / HS CODE : NET WT : . KGS |
| 2025-11-15 |
BWLEX6959112398 |
VKT PHARMA PRIVATE LIMITED |
8684.0 kg |
902230.0
|
X RH STC (FOURTY ONE ) PACKAGES TADALAF IL TABLETS,USP MG NDC NO.: - - ( X = NOS)TADALAFIL TABLETS,USP MG NDC NO.: - - ( X = NOS)I NV NO : VKT/EX/ / - DT : - - SB NO : DT : . . HS CODE : N ET WT : . KGS |
| 2025-11-15 |
BWLEX6959201794 |
VKT PHARMA PRIVATE LIMITED |
8322.0 kg |
902230.0
|
X RF STC (FOURTY ONE ) PACKAGES OF TADALA FIL TABLETS,USP . MG( CT) X BLISTERS - N DC NO: - - - X X = NOSTA DALAFIL TABLETS,USP MG - NDC NO: - - - X = NO SINV NO : VKT/EX/ / - DT : / / SB NO: / / HS CODE : NETWT: . KGS |
| 2025-11-08 |
BANQ1070298715 |
BESINS HEALTHCARE DISTRIBUTION FZ L |
4820.0 kg |
281122.0
|
TESTO GEL . % G P CTU TESTO GEL % X G P CTU LOADED ON PALLETS NET WEIGHT: KG |
| 2025-10-25 |
BWLEX6959092332 |
VKT PHARMA PRIVATE LIMITED |
15172.0 kg |
902230.0
|
TADALAFIL TABLETS,USP . MG,( CT) X BLISTE RS NDC NO.: - - ( X X = NO S)TADALAFIL TABLETS,USP MG NDC NO.: - - ( X = NOS) TADALAFIL TABLETS,USP MG NDC NO.: - - ( X = NOS) |
| 2025-10-11 |
GLXVGLLBE0003070 |
BESINS HEALTHCARE DISTRIBUTION FZ L |
2279.0 kg |
330210.0
|
ETHANOL SOLUTIONS |
| 2025-09-29 |
BANQ1069346411 |
BESINS HEALTHCARE DISTRIBUTION FZ L |
2200.0 kg |
281122.0
|
TESTO GEL . % G CTU TESTO GEL % X G P CTU USA LOADED ON PALLETS NET WEIGHT: . KG |
| 2025-09-16 |
BANQ1068931658 |
BESINS HEALTHCARE DISTRIBUTION FZ L |
9182.0 kg |
281122.0
|
TESTO GEL . % G CTU TESTO GEL % X G P CTU USA LOADED ON PALLETS NET WEIGHT: . KG DATALOGGER: TESTO GEL . % G CTU TESTO GEL % X G P CTU USA LOADED ON PALLETS NET WEIGHT: KG DATALOGGER: |
| 2025-08-23 |
BWLEX6958872962 |
VKT PHARMA PRIVATE LIMITED |
5369.0 kg |
902230
|
X RF STC (TWENTY SEVEN) PACKAGES OF TADA LAFIL TABLETS,USP . MG ( CT) X BLISTERS - NDCNO: - - - X X = NO S T ADALAFIL TABLETS,USP MG - NDCNO: - - - X = NO SINV NO : VKT/EX/ / - DT : / / SB NO: DT : / / HS CODE : NET WT : . KGS |
| 2025-08-02 |
MAEU256753158 |
|
870.0 kg |
291823
|
MEDROXYPR. 150MGML SASUS 1X1ML DSSG US FIL 3 700698 INVOICE 9771682092 OBD 8117803217 |
| 2025-07-31 |
BWLEX6958827820 |
VKT PHARMA PRIVATE LIMITED |
8153.0 kg |
300490
|
1X40RF STC 39 (THIRTY NINE )PACKAGES OFTADALAFIL TABLETS,USP 5MGNDC NO:35573-461-30(INV QTY 158904X30=4767120NOS)INV NO:VKT/EX/023/25-26DT :17/06/2025SB NO:2828325 DT: 19/06/2025HSCODE :30049099NET WT :4608.200 KGS |
| 2025-07-19 |
MAEU255681861 |
|
3136.19 kg |
291823
|
MEDROXYPR. 150MGML SASUS 1X1ML DSSG US FIL 3 692621 INVOICE 9771681476 OBD 8117689534 MEDROXYPR. 150MGML SASUS 1X1ML DSSG US FIL 3 692539 INVOICE 9771681475 OBD 8117689488 MEDROXYPR. 150MGML SASUS 1X1ML DSSG US FIL 3 692505 INVOICE 9771681470 OBD 81176894 |
| 2025-07-19 |
MAEU255681855 |
|
2237.16 kg |
291823
|
MEDROXYPR. 150MGML SASUS 1X1ML DSSG US FIL 3 692530 INVOICE 9771681473 OBD 8117658826 MEDROXYPR. 150MGML SASUS 1X1ML DSSG US FIL 3 692514 INVOICE 9771681472 OBD 8117688718 |
| 2025-07-19 |
MAEU255681849 |
|
5300.32 kg |
291823
|
MEDROXYPR. 150MGML SASUS 1X1ML DSSG US FIL 3 692940 INVOICE 9771681489 OBD 8117688708 MEDROXYPR. 150MGML SASUS 1X1ML DSSG US FIL 3 692873 INVOICE 9771681486 OBD 8117697431 MEDROXYPR. 150MGML SASUS 1X1ML DSSG US FIL 3 692821 INVOICE 9771681484 OBD 81176812 |
| 2025-06-17 |
MAEU253614549 |
|
3959.93 kg |
392330
|
MEDROXYPR. 150MG/ML SASUS 1X 1ML DSSG US FIL: 3639597 INV OICE: 9771677888 OBD: 8117028 637 MEDROXYPR. 150MG/ML SASUS 1X 1ML DSSG US FIL: 3639650 INV OICE: 9771677890 OBD: 8117029 057 MEDROXYPR. 150MG/ML SASUS 1X 1ML DSSG US FIL: 3639719 INV OICE: 9771677899 OBD: 8117029 061 |
| 2025-06-17 |
MAEU253614547 |
|
3431.94 kg |
392330
|
MEDROXYPR. 150MG/ML SASUS 1X 1ML DSSG US FIL: 3639890 INV OICE: 9771677905 OBD: 8117029 063 MEDROXYPR. 150MG/ML SASUS 1X 1ML DSSG US FIL: 3639872 INV OICE: 9771677904 OBD: 8117041 427 MEDROXYPR. 150MG/ML SASUS 1X 1ML DSSG US FIL: 3639813 INV OICE: 9771677903 OBD: 8117029 062 |
| 2025-06-12 |
BWLEMAA58669646 |
VKT PHARMA PRIVATE LIMITED |
4318.0 kg |
300490
|
1X40RF STC 22(TWENTY TWO )PACKAGES OFTADALAFIL TABLETS,USP 10MG NDC NO:35573-462-30 (INV QTY 4008X 30 =1200240NOS)TADALAFIL TABLETS,USP20MG NDC NO:35573-463-30 (INV QTY 40992X 30 =1229760 NOS)INV NO : VKT/EX/003/25-26 DT : 29/03/2025SB NO: 1405234 DT : 30 |
| 2025-06-03 |
DSVFHA60014368 |
G POHL BOSKAMP GMBH & CO |
995.0 kg |
293627
|
MEDICAMENTSREEFER CONTAINERTEMPERATURE: +4 C |
| 2025-05-25 |
MAEU252752171 |
PFIZER SERVICE COMPANY |
2873.56 kg |
392330
|
MEDROXYPR. 150MG/ML SASUS 1X 1ML DSSG US FIL: 3623577 INV OICE: 9771676838 OBD: 8116845 007 MEDROXYPR. 150MG/ML SASUS 1X 1ML DSSG US FIL: 3623625 INV OICE: 9771676841 OBD: 8116845 115 MEDROXYPR. 150MG/ML SASUS 1X 1ML DSSG US FIL: 3623667 INV OICE: 9771676 |
| 2025-05-25 |
MAEU252752167 |
|
2654.92 kg |
392330
|
MEDROXYPR. 150MG/ML SASUS 1X 1ML DSSG US FIL: 3623522 INV OICE: 9771676836 OBD: 8116893 449 MEDROXYPR. 150MG/ML SASUS 1X 1ML DSSG US FIL: 3623468 INV OICE: 9771676833 OBD: 8116860 156 |
| 2025-05-16 |
BWLEMAA58587543 |
VKT PHARMA PRIVATE LIMITED |
10129.0 kg |
300490
|
1X40RF STC 25 (TWENTY FIVE) PACKAGES OFTADALAFIL TABLETS,USP 5MG NDC NO:35573-461-30 (INV QTY 63000X 30 =1890000 NOS)TADALAFIL TABLETS,USP 10MG NDC NO:35573-462-30 (INV QTY 26136 X30 =784080NOS)INV NO : VKT/EX/075/24-25 DT : 31/03/2025SB NO:9624127 DT.02. |
| 2025-05-13 |
BWLEBUD425002181 |
CHEMICAL WORKS OF GEDEON RICHTER GYOMROI |
5473.0 kg |
300439
|
HS CODE 300439 ESTRADIOL VAGINAL CREAM |
| 2025-05-13 |
MAEU252122710 |
PFIZER SERVICE COMPANY |
3521.75 kg |
392330
|
MEDROXYPR. 150MG/ML SASUS 1X1M L DSSG US FIL: 3602078 INVOI CE: 9771675389 OBD: 811666261 2 MEDROXYPR. 150MG/ML SASUS 1X1M L DSSG US FIL: 3602021 INV OICE: 9771675385 OBD: 8116685 027 MEDROXYPR. 150MG/ML SASUS 1X1M L DSSG US FIL: 3601981 INV OICE: 9771675 |
| 2025-04-28 |
MAEU251454105 |
|
2103.34 kg |
392330
|
MEDROXYPR. 150MG/ML SASUS 1X 1ML DSSG US FIL: 3579923 I NVOICE: 9771673042 OBD: 81165 88327 MEDROXYPR. 150MG/ML SASUS 1X 1ML DSSG US FIL: 3579927 INV OICE: 9771673043 OBD: 8116588 386 |
| 2025-04-28 |
MAEU251454447 |
|
2150.97 kg |
392330
|
MEDROXYPR. 150MG/ML SASUS 1X 1ML DSSG US FIL: 3580596 I NVOICE: 9771673081 OBD: 81165 88400 MEDROXYPR. 150MG/ML SASUS 1X 1ML DSSG US FIL: 3580565 INV OICE: 9771673049 OBD: 8116588 397 |
| 2025-03-25 |
BWLEBUD425001071 |
CHEMICAL WORKS OF GEDEON RICHTER PL GYOMROI |
8309.0 kg |
300439
|
HS CODE 300439 ESTRADIOL VAGINAL CREAM |
| 2025-03-18 |
BWLEBUD425001061 |
CHEMICAL WORKS OF GEDEON RICHTER PL GYOMRORI |
8155.0 kg |
300439
|
HS CODE 300439 ESTRADIOL VAGINAL CREAM |
| 2025-03-14 |
BWLEMAA58378493 |
VKT PHARMA PRIVATE LIMITED |
3314.0 kg |
300490
|
1X20RF FCL STC 18 (EIGHTEEN ) PACKAGES OFTADALAFIL TABLETS,USP 5MG NDC NO:35573-461-30 (INV QTY 63936X 30 = 1918080 NOS)INV NO : VKT/EX/061/24-25DT : 27/01/2025SB NO :7678164 / DT.28.01.2025HS CODE : 30049099NET WT : 1854.100KGS |
| 2025-03-12 |
BWLEBUD425000901 |
CHEMICAL WORKS OF GEDEON GYOMROI |
8234.0 kg |
300439
|
ESTRADIOL VAGINAL CREAM HS CODE 300439 |
| 2025-02-05 |
BWLEMAA48290367 |
VKT PHARMA PRIVATE LIMITED |
1038.0 kg |
310510
|
TADALAFIL TABLETS |
| 2025-01-28 |
BWLELEH48204257 |
|
9508.0 kg |
300510
|
PHARMACEUTICAL PRODUCTS |
| 2025-01-19 |
MAEU247795078 |
PFIZER SERVICE COMPANY |
67.13 kg |
293499
|
AMLO/ATOR 2.5/40MG FCT 1X30 BT L PS US FIL: 3477106 INVOI CE: 9908485150 OBD: 811547252 6 AMLO/ATOR 2.5/40MG FCT 1X30 BT L PS US FIL: 3477109 INVOI CE: 9908485151 OBD: 811547478 1 |
| 2025-01-18 |
BWLEMAA48191286 |
VKT PHARMA PRIVATE LIMITED |
8299.0 kg |
300490
|
TADALAFIL TABLETS,USP 5 MG NDC NO:35573-461-30 (INV QTY 134304 X 30 = 4029120 NOS)TADALAFIL TABLETS,USP 10 MG NDC NO:35573-462-30 (INV QTY 13344 X 30 = 400320 NOS)TADALAFIL TABLETS,USP 10 MG NDC NO:35573-462-30 (INV QTY 13560X 30 = 406800 NOS)INV NO : VKT/EX/043/24-25D T : 22/11/2024INV NO :VKT/EX/041/24-25 DT :31 /10/2024SB.NO.5840322 / DT.23.11.2024SB.NO.5840541 / DT.23.11.2024HS CODE : 30049099NET WT: 4648.10 KGS |
| 2025-01-18 |
BWLEMAA48214323 |
VKT PHARMA PRIVATE LIMITED |
3255.0 kg |
300490
|
4 PKGS OF LCL STC TADALAFIL TABLETS,USP 5 MG NDC NO:35573-461-30 (INV QTY 63432 X 30 = 1902960 NOS)INV NO : VKT/EX/046/24-25DT : 27/11/2024SB NO : 5977363 / DT.28.11.2024HS CODE : 30049099NET WT : 1839.500 KGS |
| 2025-01-15 |
BWLEBUD424007921 |
CHEMICAL WORKS OF GEDEON RICHTER PL GYOMRORI |
8164.0 kg |
300439
|
HS CODE 300439 ESTRADIOL VAGINAL CREAM |
| 2025-01-07 |
BWLELEH48189665 |
|
9549.0 kg |
300510
|
PHARMACEUTICAL PRODUCTS |
| 2025-01-06 |
BWLEMAA48162311 |
VKT PHARMA PRIVATE LIMITED |
8496.0 kg |
300490
|
1X40RF STC 40 (FOURTY ) PACKAGES OFTADALAFIL TABLETS, USP 5MG NDC NO.:35573TADALAFIL TABLETS, USP 10MG NDC NO.:3557TADALAFIL TABLETS, USP 20MG NDC NO.:3557INV NO : VKT/EX/040/24-25DT : 31-10-2024SB NO: 5520047 DT : 11.11.202 4HS CODE : 30049099NET WT : 4855.9 (KGS)SCAC : BWLE |
| 2024-12-17 |
BWLEMAA48076847 |
VKT PHARMA PRIVATE LIMITED |
6753.0 kg |
300490
|
1X40RF STC 32 (THIRTY TWO )PACKAGES OFTADALAFIL TABLETS,USP 5MG NDC NO:35573-461-30 (INV QTY 131937 X 30 = 3958110 NOS)INV NO : VKT/EX/033/24-25DT : 30/09/2024SB NO :4888818 / DT.17.10.2024HS CODE : 30049099NET WT : 3825.900 KGSTEMPERATURE TO BE SET AT +25 DEG CELCIUS |
| 2024-12-17 |
BWLEMAA48076849 |
VKT PHARMA PRIVATE LIMITED |
8145.0 kg |
382590
|
1X40RF STC 38(THRITY EIGHT)PACKAGES OF |
| 2024-12-17 |
BWLEMAA48095371 |
VKT PHARMA PRIVATE LIMITED |
8443.0 kg |
300490
|
1X40RF STC 39 (THIRTY NINE ) PACKAGES OFTADALAFIL TABLETS,USP 5 MG NDC NO:35573-461-30 (INV QTY 99288 X 30 = 2978640 NOS)TADALAFIL TABLETS,USP 20 MG NDC NO:35573-463-30 (INV QTY 61224 X 30 = 1836720 NOS)INV NO :VKT/EX/037/24-25DT :23/10/2024SB NO :5096593 / DT.24.10.2024HS CODE :30049099 NET WT :4654.800 KGS TEMPE RATURE TO BE SET AS +25 DEGREE CELCIUS |
| 2024-12-10 |
BWLELEH48135256 |
|
30271.0 kg |
300510
|
PHARMACEUTICAL PRODUCTS PHARMACEUTICAL PRODUCTS PHARMACEUTICAL PRODUCTS |